Catalogue / Metabolic research
GIP / GLP-1 / GCG RA (NXP-703)
Synthetic triple receptor agonist peptide (GIP / GLP-1 / GCG), designated NXP-703.
Per unit · 1 vial
SKU PSQ-NXP703-5MG
Supply and certificate
Supplied as lyophilised powder in a sealed glass vial, in 5 mg, 10 mg and 20 mg strengths.
Batch RET-0426 was analysed by Analiza Białek sp. z o.o. between 22 and 25 May 2026. The report gives a measured content of 5.74 mg for a vial labelled 5 mg, with the purity figure and chromatogram. The gradient for this compound starts at 40 % acetonitrile rather than 5 %.
The report is reproduced in full on the certificate page, with its lab order number and verification code.
Specification
| Presentation | Lyophilised powder, sealed glass vial |
|---|---|
| Strength | 5 mg · 10 mg · 20 mg |
| Unit | 1 vial |
| CAS | 2381089-83-2 |
| Formula | C221H342N46O68 |
| Molecular weight | 4731.3 g/mol, free base |
| Purity | See report |
| Identity (MS) | See report |
| Certificate | RET-0426 · issued 25 May 2026 · code D2UK19M4 |
Research use
All products are supplied for in-vitro laboratory research only. They are not medicines, not for human or veterinary use, not for food use, and are not offered for the diagnosis, treatment, cure or prevention of any condition. No protocol, quantity or method of administration is supplied with any product. Determining suitability for a given experiment is the researcher’s responsibility. By purchasing you confirm you are a qualified researcher.